For clinical labs, bloodstream infection testing encompasses a broad range of pathogens and is increasingly important for antimicrobial stewardship programs. From tracking antibiotic resistance markers in bacteria to diagnosing sepsis, a costly and life-threatening response to blood infection, patient care depends on getting reliable lab results quickly. Speed is so important because a sepsis patient’s mortality rate increases by 7.6% each hour that appropriate antibiotic treatment is delayed.1
Whether you’re focused on identifying causative pathogens or infection control, we have solutions to help.
Our portfolio of bloodstream infection diagnostics empowers clinical labs to identify pathogens and associated resistance markers, all with assay flexibility and scalability. These rapid blood culture tests can cut 24 to 48 hours off traditional test turnaround time, which has been shown to shorten hospital stays, lower costs, and improve outcomes by getting the right drug to the patient faster.2 In conjunction with antimicrobial stewardship programs, this approach also successfully reduces the use of unnecessary antibiotics.
Learn more about our bloodstream infection testing options:
Impact of Antimicrobial Stewardship and Rapid Microarray Testing on Patients with Gram-Negative Bacteremia — Outcomes Study from Cleveland Clinic
Identification of Gram-Negative Bacteria and Genetic Resistance Determinants from Positive Blood Culture Broths by Use of the VERIGENE Gram-Negative Blood Culture Multiplex Microarray-Based Molecular Assay — Journal of Clinical Microbiology
For In Vitro Diagnostic Use. Products are region specific and may not be approved in some countries/regions. Please contact Luminex at email@example.com to obtain the appropriate product information for your country of residence.